#Clinical Next-Generation Sequencing (NSG) Testing Market Demand

[roseaa11]

Technological advancements in the clinical next-generation sequencing (NSG) testing coupled with rising research and development proficiencies are fostering the market growth. Data Bridge Market Research analyses that the clinical next-generation sequencing (NSG) testing market will exhibit a CAGR of around 27.25% for the forecast period of 2021-2028.

[researchtrendingnews]

Clinical Next-Generation Sequencing Testing Market Strategic Insights and key Business Influencing Factors | Major Players – Adaptive Biotechnologies, Admera Health, Agilent Technologies, Inc., ALCEN, Almac Group.

Clinical Next-Generation Sequencing Testing Market are next generation sequencing ,second generation sequencing or massively parallel sequencing are related terms, which is used to sequence the genomes at high speed and at low cost. They are usually used to identify the order of adenine, guanine, cytosine and thymine. These days there is increase in the demand for robust sequencing-based diagnostics which is the major factor fueling the growth of this market.

Global Clinical Next- Generation Sequencing (NSG) Testing Market is expected to rise from its initial estimated value of USD 51.81 billion to an estimated value of USD 356.18 billion by 2026, registering a CAGR of 27.25% in the forecast period of 2019-2026. Technological advancement in the next- generation sequencing (NSG) platform is major factor for the growth of this market.

 Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-next-generation-sequencing-nsg-testing-market

Competitive Analysis: Global Clinical Next-Generation Sequencing Testing   Market

Few of the major competitors currently working in the clinical next- generation sequencing (NSG) testing market are 3billion, Inc.,  10x Genomics., 23andMe, Inc., Adaptive Biotechnologies, Admera Health, Agilent Technologies, Inc., ALCEN, Almac Group, AMARANTUS BIOSCIENCE HOLDINGS, INC, Ambry Genetics, Aperiomics, Inc., ARUP Laboratories, ASURAGEN, INC., Athena Diagnostics, Inc., Atreca, Inc., Base4, Baylor Genetics, BD, Berry Gene, BGI,  Bioarray S.L, Biodesix, Inc., Boreal Genomics Inc., Cambridge Epigenetix Limited.

 Key Pointers Covered in the Global Clinical Next-Generation Sequencing Testing Market Trends and Forecast to 2026

Global   Clinical Next-Generation Sequencing Testing Market New Sales Volumes

Global   Clinical Next-Generation Sequencing Testing  Market Replacement Sales Volumes

Global   Clinical Next-Generation Sequencing Testing Market Installed Base

Global   Clinical Next-Generation Sequencing Testing Market By Brands

Global   Clinical Next-Generation Sequencing Testing Market Size

Global   Clinical Next-Generation Sequencing Testing  Market Procedure Volumes

Global   Clinical Next-Generation Sequencing Testing Market Product Price Analysis

Global   Clinical Next-Generation Sequencing Testing Market Healthcare Outcomes

Global   Clinical Next-Generation Sequencing Testing Market Cost of Care Analysis

Global   Clinical Next-Generation Sequencing Testing Market Regulatory Framework and Changes

Global   Clinical Next-Generation Sequencing Testing Market Prices and Reimbursement Analysis

Global   Clinical Next-Generation Sequencing Testing Market Shares in Different Regions

Recent Developments for Global   Clinical Next-Generation Sequencing Testing Market Competitors

Global   Clinical Next-Generation Sequencing Testing Market Upcoming Applications

Global   Clinical Next-Generation Sequencing Testing Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-clinical-next-generation-sequencing-nsg-testing-market

Key Developments in the Market:

In February 2019, Agilent Technologies, Inc. announced the launch of their next generation sequencing Magnis NGS Prep System that is specially designed for composite DNA sequencing assays. It will make it easy to evaluate multiple genes and complex genetic aberrations from genomic DNA. The main aim is to provide solution that is easy to use and will increase the sequencing reproducibility.

In October 2017, GENEWIZ announced the launch of the CLIA Sanger sequencing and new NGS amplicon sequencing. The main aim is to provide the customers with better services. Amplicon EZ is specially designed so that researcher can deploy the      next generation sequencing and CLIA Sanger Sequencing service will allow the work to be done in both research and clinical environments.

 Scope of the Clinical Next-Generation Sequencing Testing Market

Global Clinical Next-Generation Sequencing (NSG) Testing Market By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural & Animal Research, Other Applications), End- User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal & Plant Sequencing,  Other Sequencing Services), Workflow (Pre-sequencing, Sequencing, Data Analysis), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Global Clinical Next- Generation Sequencing (NSG) Testing Market is expected to rise from its initial estimated value of USD 51.81 billion to an estimated value of USD 356.18 billion by 2026, registering a CAGR of 27.25% in the forecast period of 2019-2026. Technological advancement in the next- generation sequencing (NSG) platform is major factor for the growth of this market.

Next generation sequencing ,second generation sequencing or massively parallel sequencing are related terms, which is used to sequence the genomes at high speed and at low cost. They are usually used to identify the order of adenine, guanine, cytosine and thymine. These days there is increase in the demand for robust sequencing-based diagnostics which is the major factor fueling the growth of this market.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-clinical-next-generation-sequencing-nsg-testing-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Browse Related Report Here:

Guidewires Market

Surgical Glue Market

[monaligvr-blog]

Liquid Handling Technology Market Returns Is To Reach A Value Of $5.54 Billion Forecast Till 2025

San Francisco, 1 November 2018 - According to a report by Grand View Research, Inc., global liquid handling technology market is anticipated to value USD 6.99 billion by 2025. Growing requirement for precision and acceleration in laboratory workflow coupled with rising investment in drug discovery can surge demand for liquid handling technology. The technology is likely to reduce operational cost by avoiding excess use of expensive reagents during research and development activities.

High demand for effective miniaturization of workflow processes is anticipated to fuel demand for high –throughput liquid handling technology. This, in turn can augment growth of market. In addition, rising trend for adopting robotics and automation in clinical trials and drug discovery can stimulate growth of market over next few years. Moreover, increasing salary of highly skilled professionals is anticipated to surge demand for advanced technology in clinical research and drug discovery. This, in turn, can spur growth of market during the forecast period (2014 to 2025).

The liquid handling technology market can be segregated on the basis of product, type, application, end-user, and region. Based on product, the market can be categorized into small devices, automated workstations, consumables.

Based on type, the market can be classified into manual liquid handling, automated liquid handling, and semi-automated liquid handling. Automated liquid handling segment is expected to witness significant growth owing to high demand for cutting-edge technology. Introduction of innovations such as CRISPR and next generation sequencing (NGS) can fuel demand for automation.

Browse Research Report On Liquid Handling Technology Market : www.grandviewresearch.com/industry-analysis/liquid-handling-technology-market

Similarly, growing need for human skills and customization in high-throughput experimentation can surge demand for manual liquid handling technology.

Based on application, the market can be segmented into cancer & genomic research, drug discovery & ADME-Tox research, bioprocessing, and others. Drug discovery & ADME-Tox research is expected to contribute well for growth of market during the forecast period. Growing adoption of microarray technology in combination with liquid handling technology to simply screening and testing of drugs can influence market growth. Rising need to assay multiple samples in different volumes and environments is expected to surge demand for these advanced technologies.

On the contrary, cancer & genomic research segmented is estimated to fuel use of liquid handling technology. Continual innovations in biotechnology such as NSG and CRISPR-Cas9 is likely to accelerate pace of genomic research. This, in turn, is expected to encourage investments in new research including mutation-based disease treatment and disease mechanism studies. In addition, increasing financial support from public and private entities for regenerative medicine and oncology research can fuel adoption of liquid handling technology during the forecast period.

Based on end-user, the market can be divided into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. Pharmaceutical & biotechnological companies are expected to contribute well for market growth owing to rising number of clinical trials coupled with growing adoption of outsourcing services. In addition, increasing number of contract research organizations (CROs) adopting liquid handling technology to meet outsourcing requirement of these players is likely to contribute to revenue generation.

Similarly, academic & research institutes are likely to contribute to growth of market owing to rising government investments in infrastructural development of these institutes. In addition, collaborations between major market players and universities equipped with established research facilities can augment market growth.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America dominated the market and accounted for largest market share. Growing adoption of advanced instrumentation technology in research can fuel growth of market. In addition, high prevalence of major players in the region collaborating with well-established universities and research centers in Europe to expand their distribution channel can influence market growth.

Hence, in Europe, the market is expected to witness significant growth owing to huge customer base in the form of academic and research institutes in the region.

On the contrary, Asia Pacific is likely to grow well over the forecast period attributed to effective developments registered by emerging countries in biotechnology, pharmaceutical, and academic sectors can fuel market growth. In addition, growing investments in life science sectors including drug development, clinical diagnostics, microbiology, and omics research by China and Japan can fuel market growth in the region.

Some of the leading companies offering liquid handling technology are Agilent Technologies, Bio-Rad Laboratories, Borosil Glass Works Ltd., Corning Incorporated, and Hudson Robotics.

View more reports of this category by Grand View Research at www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global liquid handling technology market report on the basis of product, type, application, end user, and region:

Product Outlook (Revenue, USD Million; 2014 - 2025)

Automated Workstations

Standalone Workstations

Integrated Workstations

Small Devices

Pipettes

Electronic Pipettes

Manual Pipettes

Pipette Controllers

Burettes

Dispensers

Others

Consumables

Regents

Disposable Tips

Tubes & Plates

Others

Type Outlook (Revenue, USD Million; 2014 - 2025)

Automated Liquid Handling

Manual Liquid Handling

Semi-Automated Liquid Handling

Application Outlook (Revenue, USD Million; 2014 - 2025)

Drug Discovery & ADME-Tox Research

Cancer & Genomic Research

Bioprocessing/Biotechnology

Others

End User Outlook (Revenue, USD Million; 2014 - 2025)

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Regional Outlook (Revenue, USD Million; 2014 - 2025)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-liquid-handling-technology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

[marketresearchinsight-blog]

Liquid Handling Technology Market Is Expected To Experience Huge Growth Over The Forecast Period

San Francisco, 30 October 2018 - According to a report by Grand View Research, Inc., global liquid handling technology market is anticipated to value USD 6.99 billion by 2025. Growing requirement for precision and acceleration in laboratory workflow coupled with rising investment in drug discovery can surge demand for liquid handling technology. The technology is likely to reduce operational cost by avoiding excess use of expensive reagents during research and development activities.

High demand for effective miniaturization of workflow processes is anticipated to fuel demand for high –throughput liquid handling technology. This, in turn can augment growth of market. In addition, rising trend for adopting robotics and automation in clinical trials and drug discovery can stimulate growth of market over next few years. Moreover, increasing salary of highly skilled professionals is anticipated to surge demand for advanced technology in clinical research and drug discovery. This, in turn, can spur growth of market during the forecast period (2014 to 2025).

The liquid handling technology market can be segregated on the basis of product, type, application, end-user, and region. Based on product, the market can be categorized into small devices, automated workstations, consumables.

Access Full Insights And Data On Liquid Handling Technology Market: www.grandviewresearch.com/industry-analysis/liquid-handling-technology-market

Based on type, the market can be classified into manual liquid handling, automated liquid handling, and semi-automated liquid handling. Automated liquid handling segment is expected to witness significant growth owing to high demand for cutting-edge technology. Introduction of innovations such as CRISPR and next generation sequencing (NGS) can fuel demand for automation.

Similarly, growing need for human skills and customization in high-throughput experimentation can surge demand for manual liquid handling technology.

Based on application, the market can be segmented into cancer & genomic research, drug discovery & ADME-Tox research, bioprocessing, and others. Drug discovery & ADME-Tox research is expected to contribute well for growth of market during the forecast period. Growing adoption of microarray technology in combination with liquid handling technology to simply screening and testing of drugs can influence market growth. Rising need to assay multiple samples in different volumes and environments is expected to surge demand for these advanced technologies.

On the contrary, cancer & genomic research segmented is estimated to fuel use of liquid handling technology. Continual innovations in biotechnology such as NSG and CRISPR-Cas9 is likely to accelerate pace of genomic research. This, in turn, is expected to encourage investments in new research including mutation-based disease treatment and disease mechanism studies. In addition, increasing financial support from public and private entities for regenerative medicine and oncology research can fuel adoption of liquid handling technology during the forecast period.

Based on end-user, the market can be divided into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. Pharmaceutical & biotechnological companies are expected to contribute well for market growth owing to rising number of clinical trials coupled with growing adoption of outsourcing services. In addition, increasing number of contract research organizations (CROs) adopting liquid handling technology to meet outsourcing requirement of these players is likely to contribute to revenue generation.

Similarly, academic & research institutes are likely to contribute to growth of market owing to rising government investments in infrastructural development of these institutes. In addition, collaborations between major market players and universities equipped with established research facilities can augment market growth.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America dominated the market and accounted for largest market share. Growing adoption of advanced instrumentation technology in research can fuel growth of market. In addition, high prevalence of major players in the region collaborating with well-established universities and research centers in Europe to expand their distribution channel can influence market growth.

Hence, in Europe, the market is expected to witness significant growth owing to huge customer base in the form of academic and research institutes in the region.

On the contrary, Asia Pacific is likely to grow well over the forecast period attributed to effective developments registered by emerging countries in biotechnology, pharmaceutical, and academic sectors can fuel market growth. In addition, growing investments in life science sectors including drug development, clinical diagnostics, microbiology, and omics research by China and Japan can fuel market growth in the region.

Some of the leading companies offering liquid handling technology are Agilent Technologies, Bio-Rad Laboratories, Borosil Glass Works Ltd., Corning Incorporated, and Hudson Robotics.

Access more reports of the same category: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global liquid handling technology market report on the basis of product, type, application, end user, and region:

Product Outlook (Revenue, USD Million; 2014 - 2025)

Automated Workstations

Small Devices

Consumables

Standalone Workstations

Integrated Workstations

Pipettes

Burettes

Dispensers

Others

Electronic Pipettes

Manual Pipettes

Pipette Controllers

Regents

Disposable Tips

Tubes & Plates

Others

Type Outlook (Revenue, USD Million; 2014 - 2025)

Automated Liquid Handling

Manual Liquid Handling

Semi-Automated Liquid Handling

Application Outlook (Revenue, USD Million; 2014 - 2025)

Drug Discovery & ADME-Tox Research

Cancer & Genomic Research

Bioprocessing/Biotechnology

Others

End User Outlook (Revenue, USD Million; 2014 - 2025)

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Regional Outlook (Revenue, USD Million; 2014 - 2025)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-liquid-handling-technology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

[healthy-insights]

Next-generation Cancer Diagnostics Market :Competitive Dynamics & Global Outlook 2024

The cancer diagnostics industry is projected to witness lucrative growth in the next few years due to the increasing number of technologically advanced products providing accurate test results in the field of diagnostics. Additionally, they also help with therapeutic monitoring and early diagnosis of cancer. Significant improvements observed in the shift from traditional laboratory testing to rapid point of care testing (POC) drive this market. Commercialization of products such as diagnostic kits, instruments, reagents, and consumables plays a role as well. The decreasing cost of genetic sequencing, rising incidence of cancer, increasing interest in the microfluidic hip technology, and the use of circulating tumor cells (CTCs) in cancer management have also aided the development of the next-generation cancer diagnostics market.

Government measures taken by developed and developing countries to increase the number of research projects in accordance with oncology and preventative diagnosis are anticipated to propel the next-generation cancer diagnostics market over the next few years. The application of tumor diagnostics in the epigenetic analysis and CTC enumeration sectors to monitor tumorigenesis is predicted to make a difference as well. However, the market may be limited by the high laboratory infrastructure costs involved. Insufficient reimbursement policies for innovative technologies and the stringent regulatory procedures and guidelines followed by the government are other factors affecting the global next-generation cancer diagnostics market.

This market is segmented by technology into the following categories: qPCR & multiplexing, protein microarrays, next-generation sequencing (NSG), DNA microarrays, lab-on-a-chip, and reverse transcriptase-PCR (RT-PCR), of which microarrays and PCR are expected to dominate the market due to their rising usage in invitro diagnostics by hospitals and private diagnostics clinics.

Browse full report on Next-generation Cancer Diagnostics Market -

http://www.transparencymarketresearch.com/next-generation-cancer-diagnostics-market.html

Based on application, the next-generation cancer diagnostics market is classified into the following groups: genetic analysis, biomarker development, epigenetic analysis, and CTC analysis & proteomic analysis, of which biomarkers and CTC analysis are likely to drive the market as these techniques are widely used in drug discovery and development.

The market, in terms of cancer type, is divided into the cervical, breast, colorectal, lung, and other varieties. Its function-based divisions are cancer screening, companion diagnostics, therapeutic monitoring, prognostics, and risk analysis, of which diagnostics and therapeutic monitoring are projected to be the leading segments.

Geographically the next-generation cancer diagnostics market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the market due to favorable government initiatives (such as the “80% by 2018” movement for colon cancer detection), healthy R&D investments, personalized medicine, development of next-generation sequencing, and availability of a technologically advanced health care research framework. The market in Asia Pacific is projected to register a prominent growth rate owing to the development of health care infrastructure, significantly large untapped market base, and economic development in the region.

Prominent players in the next-generation cancer diagnostics market include Thermo Fisher Scientific, Inc; Opko Health, Inc;  Myriad Genetics, Inc.; Agilent Technologies; GE Healthcare Cepheid; Koninklijke Philips N.V; F. Hoffmann-La Roche Ltd; Qiagen; Novartis AG; Abbott; PerkinElmer, Inc.; Genomic Health, Inc.; Illumina, Inc; and Sysmex Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

Middle East and Africa (GCC, Southern Africa, and North Africa)

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19568

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com